Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.38 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA3 | P07451 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186903 | 0.80 | PGK1 (0.45) | — | |
| SCHEMBL15136324 | 0.77 | PGK1 (0.43) | — | |
| Ammonia Solution, Strong SCHEMBL6471811 | 0.77 | PGK1 (0.43) | — | |
| SCHEMBL12469733 | 0.77 | PGK1 (0.43) | — | |
| SCHEMBL4017894 | 0.77 | PGK1 (0.43) | — | |
| Phosphoric Acid SCHEMBL5177945 | 0.74 | LMNA (0.58) | FDPSLMNABLMCYP3A4NFKB1 | |
| Diaminooctane SCHEMBL31657014 | 0.74 | LMNA (0.58) | FDPSLMNABLMCYP3A4NFKB1 | |
| Phosphoric Acid SCHEMBL5382781 | 0.74 | LMNA (0.58) | FDPSLMNABLMCYP3A4NFKB1 | |
| Phosphoric Acid SCHEMBL31656949 | 0.74 | LMNA (0.58) | FDPSLMNABLMCYP3A4NFKB1 | |
| Phosphoric Acid SCHEMBL14974535 | 0.74 | LMNA (0.58) | FDPSLMNABLMCYP3A4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1495035-B1 | METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF | MERCK PATENT GMBH (DE) | 2010-06-30 | — | — | EP | disclosed |
| US-7202379-B2 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | MERCK PATENT GMBH (DE) | 2007-04-10 | — | — | US | disclosed |
| US-20050256334-A1 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | MERCK PATENT GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
| EP-1495035-A1 | METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF | MERCK PATENT GmbH (DE) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003087110-A1 | METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF | MERCK PATENT GMBH (DE) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256334-A1 | Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof | PFAS, PFKFB1, PFKFB4 | FDPS 34/4885LMNA 3301/4885BLM 1777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.